Analysts hammer Salix, though say it might now be a takeover candidate

Analysts largely hammered Salix Pharmaceuticals because of misstated inventory levels, a day after company shares dropped 35 percent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.